Mantovani, G., Bastepe, M., Monk, D., De Sanctis, L., Thiele, S., Ahmed, S. F., Bufo, R., Choplin, T., De Filippo, G., Devernois, G., Eggermann, T., Elli, F. M., Garcia Ramirez, A., Germain-Lee, E. L., Groussin, L., Hamdy, N. A. T., Hanna, P., Hiort, O., Jüppner, H. ... Linglart, A. (2020).
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.
Hormone Research in Paediatrics,
93(3), 182-196.
https://doi.org/10.1159/000508985Mathieu, C., Dandona, P., Birkenfeld, A. L.
, Hansen, T. K., Iqbal, N., Xu, J., Repetto, E., Scheerer, M. F., Thoren, F. & Phillip, M. (2020).
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2.
Diabetes, Obesity and Metabolism,
22(11), 2151-2160.
https://doi.org/10.1111/dom.14144McClung, M. R., Bolognese, M. A., Brown, J. P., Reginster, J. Y.
, Langdahl, B. L., Maddox, J., Shi, Y., Rojeski, M., Meisner, P. D. & Grauer, A. (2020).
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Osteoporosis International,
31(11), 2231-2241.
https://doi.org/10.1007/s00198-020-05502-0McIntyre, H. D., Gibbons, K. S., Ma, R. C. W., Tam, W. H., Sacks, D. A., Lowe, J.
, Madsen, L. R. & Catalano, P. M. (2020).
Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia.
Diabetes Research and Clinical Practice,
167, Article 108353.
https://doi.org/10.1016/j.diabres.2020.108353